Duopharma Biotech group managing director Leonard Ariff Abdul Shatar
KUALA LUMPUR: Duopharma Biotech Bhd
will resume looking at mergers and acquisitions (M&A) opportunities especially within ASEAN to remain relevant over the longer term and grow.
Group managing director Leonard Ariff Abdul Shatar said the company has been relatively successful in penetrating the Malaysian market with a market share of seven per cent despite being the largest manufacturer.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
